Aero Healthcare Recalls Acetaminophen 500mg Caffeine 65mg caplets
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Aero Healthcare Recalls Acetaminophen 500mg Caffeine 65mg caplets
Aero Healthcare · Class II — Moderate Risk

Product Description
Acetaminophen 500mg Caffeine 65mg caplets, packaged as 2 caplets per packet further packaged in a 50-count box, AERO TAB, Manufactured for AERO HEALTHCARE US, Valley-Cottage, NY, 10989, NDC 55305-135-01
Reason for Recall
Labeling: Label Mix-up. This issue affects the outer box labeling only. The box incorrectly states the ingredients Acetaminophen 500mg and Caffeine 65mg. The inner pouch correctly states the ingredients are Aspirin (NSAID)*500mg and Caffeine 32.5mg.
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
US Nationwide.
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. Aero Healthcare initiated the recall on October 17, 2025. Labeling: Label Mix-up. This issue affects the outer box labeling only. The box incorrectly states the ingredients Acetaminophen 500mg and Caffeine 65mg. The product was distributed in US Nationwide. Consumers should check their purchases and discontinue use of any affected product. Contact Aero Healthcare for further instructions.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.